Gossamer Bio Announces First Quarter 2020 Financial Results and Provides Corporate Update

SAN DIEGO–(BUSINESS WIRE)—- $GOSS–Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology, today announced its financial results for the first quarter 2020 and provided a corporate update. “We are very pleased today to share initial results of the Gossamer team’s great execution and hard work, including that we have successfully completed t